President Trump Received Experimental Antibody Treatment

President Trump Received Experimental Antibody Treatment

Mr. Trump received a single dose of an antibody cocktail made by the biotech company Regeneron. The company’s C.E.O. has known the president for years. President Trump has received a dose of an experimental antibody cocktail being developed by the drug maker Regeneron, in addition to several other drugs, including zinc, vitamin D and the …

Read morePresident Trump Received Experimental Antibody Treatment

Experts think monoclonal antibodies could be best option for COVID-19 treatment

Experts think monoclonal antibodies could be best option for COVID-19 treatment

The Washington Post (9/30, A1, Johnson) reports many experts think a drug, called a monoclonal antibody cocktail, “could be the best bet to defang the novel coronavirus and transform it from a potentially lethal infection into a treatable illness.” NIH Director Francis Collins said it is “a real best chance of being a game changer.” Meanwhile, Janet Woodcock, …

Read moreExperts think monoclonal antibodies could be best option for COVID-19 treatment

Regeneron Antibody Cocktail Lowers Virus in Covid Patients coronavirus covid-19

Regeneron Antibody Cocktail Lowers Virus in Covid Patients

A Regeneron Pharmaceuticals Inc. antibody cocktail may help treat coronavirus patients outside of the hospital by reducing virus levels and symptoms, early study results indicate. In an early-stage clinical trial of 275 Covid-19 patients, those who received Regeneron’s experimental therapy had lower virus levels in the bloodstream seven days later compared with patients who received a placebo, …

Read moreRegeneron Antibody Cocktail Lowers Virus in Covid Patients

COVID-19

Fauci Dishes on COVID-19 Antibody Therapies

NIAID director talks to MedPage Today about a treatment approach mostly flying under the media radar by MedPage Today Staff August 31, 2020 In this “inbetweenisode” of our podcast Anamnesis, MedPage Today’s infectious disease reporter Molly Walker interviews National Institute of Allergy and Infectious Diseases Director Anthony Fauci, MD, specifically asking about a promising line of attack on COVID-19 that has …

Read moreFauci Dishes on COVID-19 Antibody Therapies

Fauci on Highly Specific, Direct Therapy for COVID-19

Fauci on ‘Highly Specific, Direct’ Therapy for COVID-19

Can monoclonal antibodies duplicate the success with Ebola in COVID-19? by Molly Walker, Associate Editor, MedPage TodayAugust 28, 2020 Monoclonal antibodies could hold promise in COVID-19 treatment and prevention if the results bear out in clinical trials for efficacy, the nation’s leading infectious diseases expert told MedPage Today. “There’s a lot of activity and it’s a …

Read moreFauci on ‘Highly Specific, Direct’ Therapy for COVID-19

ANTIBODY MEDICINES AND VACCINES

How Antibody Medicines and Vaccines Compare — and How Both Might Help Against COVID-19

When the human body encounters pathogens like SARS-CoV-2, the virus that causes COVID-19, the body’s immune system naturally produces antibodies to recognize and kill or neutralize the dangerous invaders. The immune system typically remembers its reaction to a pathogen and can produce the same protective antibodies again in the future. This is called IMMUNOLOGICAL MEMORY. …

Read moreHow Antibody Medicines and Vaccines Compare — and How Both Might Help Against COVID-19

REGENERON

Regeneron’s science chief on starting clinical trials for Covid-19 antibody drug

Dr. George Yancopoulos, chief scientific officer at Regeneron, joins CNBC’s Meg Tirrell and the “Squawk Box” crew to discuss the company’s start of the first clinical trials for its Covid-19 antibody drug. Regeneron Pharmaceuticals announced Thursday that it’s started the first clinical trial of its experimental coronavirus antibody drug. The antibody cocktail is being tested …

Read moreRegeneron’s science chief on starting clinical trials for Covid-19 antibody drug